| Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion: twelve-month study results JA Haller, F Bandello, R Belfort Jr, MS Blumenkranz, M Gillies, J Heier, ... Ophthalmology 118 (12), 2453-2460, 2011 | 890 | 2011 |
| Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double … JS Heier, AM Khanani, CQ Ruiz, K Basu, PJ Ferrone, C Brittain, ... The Lancet 399 (10326), 729-740, 2022 | 325 | 2022 |
| Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two … CC Wykoff, F Abreu, AP Adamis, K Basu, DA Eichenbaum, Z Haskova, ... The Lancet 399 (10326), 741-755, 2022 | 277 | 2022 |
| Current and upcoming anti-VEGF therapies and dosing strategies for the treatment of neovascular AMD: a comparative review S Khanna, R Komati, DA Eichenbaum, I Hariprasad, TA Ciulla, ... BMJ open ophthalmology 4 (1), e000398, 2019 | 112 | 2019 |
| Ranibizumab induces regression of diabetic retinopathy in most patients at high risk of progression to proliferative diabetic retinopathy CC Wykoff, DA Eichenbaum, DB Roth, L Hill, AE Fung, Z Haskova Ophthalmology Retina 2 (10), 997-1009, 2018 | 98 | 2018 |
| Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial AM Khanani, SS Patel, G Staurenghi, R Tadayoni, CJ Danzig, ... The Lancet 402 (10411), 1449-1458, 2023 | 73 | 2023 |
| Early experience with brolucizumab treatment of neovascular age-related macular degeneration AB Enríquez, CR Baumal, AM Crane, AJ Witkin, DR Lally, MC Liang, ... JAMA ophthalmology 139 (4), 441-448, 2021 | 69 | 2021 |
| Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial SS Patel, DR Lally, J Hsu, CC Wykoff, D Eichenbaum, JS Heier, GJ Jaffe, ... Eye 37 (17), 3551-3557, 2023 | 57 | 2023 |
| Optimal management of pigment epithelial detachments in eyes with neovascular age-related macular degeneration AM Khanani, D Eichenbaum, PG Schlottmann, L Tuomi, D Sarraf Retina 38 (11), 2103-2117, 2018 | 42 | 2018 |
| Real-world performance of a self-operated home monitoring system for early detection of neovascular age-related macular degeneration AC Ho, JS Heier, NM Holekamp, RA Garfinkel, B Ladd, CC Awh, ... Journal of Clinical Medicine 10 (7), 1355, 2021 | 37 | 2021 |
| Angiopoietins as potential targets in management of retinal disease AM Khanani, MW Russell, AA Aziz, CJ Danzig, CY Weng, ... Clinical Ophthalmology, 3747-3755, 2021 | 36 | 2021 |
| Two-year interim safety results of the 0.2 µg/day fluocinolone acetonide intravitreal implant for the treatment of diabetic macular oedema: the observational PALADIN study SE Mansour, DF Kiernan, DB Roth, D Eichenbaum, NM Holekamp, ... British Journal of Ophthalmology 105 (3), 414-419, 2021 | 30 | 2021 |
| Home monitoring of age-related macular degeneration: utility of the ForeseeHome device for detection of neovascularization JY Hannah, DF Kiernan, D Eichenbaum, VS Sheth, CC Wykoff Ophthalmology Retina 5 (4), 348-356, 2021 | 29 | 2021 |
| Geographic atrophy: clinical impact and emerging treatments HR Patel, D Eichenbaum Ophthalmic Surgery, Lasers and Imaging Retina 46 (1), 8-13, 2015 | 29 | 2015 |
| A randomized controlled trial of OPT-302, a VEGF-C/D inhibitor for neovascular age-related macular degeneration TL Jackson, J Slakter, M Buyse, K Wang, PU Dugel, CC Wykoff, DS Boyer, ... Ophthalmology 130 (6), 588-597, 2023 | 22 | 2023 |
| Macular thickness amplitude changes when switching from discontinuous to continuous therapy for diabetic macular oedema SA Schechet, OE Adams, DA Eichenbaum, SM Hariprasad BMJ open ophthalmology 4 (1), e000271, 2019 | 19 | 2019 |
| YOSEMITE and RHINE Investigators. Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema … CC Wykoff, F Abreu, AP Adamis, K Basu, DA Eichenbaum, Z Haskova, ... Lancet 399 (10326), 741-755, 2022 | 17 | 2022 |
| Monthly versus treat-and-extend ranibizumab for diabetic macular edema: a prospective, randomized trial DA Eichenbaum, E Duerr, HR Patel, SM Pollack Ophthalmic Surgery, Lasers and Imaging Retina 49 (11), e191-e197, 2018 | 17 | 2018 |
| Inhibition of complement factor 3 in geographic atrophy with NGM621: phase 1 dose-escalation study results CC Wykoff, V Hershberger, D Eichenbaum, E Henry, HS Younis, ... American Journal of Ophthalmology 235, 131-142, 2022 | 15 | 2022 |
| Evolving guidelines for intracameral injection JM Liebmann, K Barton, RN Weinreb, DA Eichenbaum, PK Gupta, ... Journal of glaucoma 29, S1-S7, 2020 | 15 | 2020 |
Jeffrey Heier在 eyeboston.com 的电子邮件经过验证
